» Articles » PMID: 11693758

Detection and Prediction of Acute Heart Transplant Rejection with the Myocardial T2 Determination Provided by a Black-blood Magnetic Resonance Imaging Sequence

Overview
Date 2001 Nov 6
PMID 11693758
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study aimed to determine whether the myocardial T2 relaxation time, determined using a black-blood magnetic resonance imaging (MRI) sequence, could predict acute heart transplant rejection.

Background: The use of black-blood MRI sequences allows suppression of the confusing influence of blood signal when myocardial T2 is calculated to detect myocardial edema.

Methods: A total of 123 investigations, including cardiac MRI and myocardial biopsy, were performed 8 +/- 11 months after heart transplantation. Myocardial T2 was determined using an original inversion-recovery/spin-echo sequence.

Results: A higher than normal T2 (> or = 56 ms) allowed an accurate detection of the moderate acute rejections evidenced at baseline biopsy (> or = International Society for Heart and Lung Transplantation grade 2): sensitivity, 89% and specificity, 70% (p < 0.0001). T2 was increased in grade 2 (n = 11) compared with grade 0 (n = 49, p < 0.05), grade 1A (n = 34, p < 0.05) and grade 1B (n = 21, p < 0.05); T2 was further increased in grade 3 (n = 8) compared with grade 2 (p < 0.05). In addition, in patients without rejection equal to or greater than grade 2 at baseline, a T2 higher than normal (> or = 56 ms) was correlated with the subsequent occurrence of equal or greater than grade 2 rejection within the next three months: sensitivity 63% (12/19) and specificity 78% (64/82) (p = 0.001).

Conclusions: Myocardial T2 determined using a black-blood MRI sequence, is sufficiently sensitive to identify most of the moderate acute rejections documented with biopsy at the same time, but is also a predictor of the subsequent occurrence of such biopsy-defined rejections.

Citing Articles

Feasibility and Role of Cardiac Magnetic Resonance in Intensive and Acute Cardiovascular Care.

Leo I, Figliozzi S, Ielapi J, Sicilia F, Torella D, Dellegrottaglie S J Clin Med. 2025; 14(4).

PMID: 40004642 PMC: 11856486. DOI: 10.3390/jcm14041112.


Imaging Methods: Magnetic Resonance Imaging.

Thomas K, Fotaki A, Botnar R, Ferreira V Circ Cardiovasc Imaging. 2023; 16(1):e014068.

PMID: 36649450 PMC: 7614460. DOI: 10.1161/CIRCIMAGING.122.014068.


T2 mapping in myocardial disease: a comprehensive review.

OBrien A, Gil K, Varghese J, Simonetti O, Zareba K J Cardiovasc Magn Reson. 2022; 24(1):33.

PMID: 35659266 PMC: 9167641. DOI: 10.1186/s12968-022-00866-0.


The Road Toward Reproducibility of Parametric Mapping of the Heart: A Technical Review.

Ogier A, Bustin A, Cochet H, Schwitter J, van Heeswijk R Front Cardiovasc Med. 2022; 9:876475.

PMID: 35600490 PMC: 9120534. DOI: 10.3389/fcvm.2022.876475.


Myocardial oedema: pathophysiological basis and implications for the failing heart.

Vasques-Novoa F, Angelico-Goncalves A, Alvarenga J, Nobrega J, Cerqueira R, Mancio J ESC Heart Fail. 2022; 9(2):958-976.

PMID: 35150087 PMC: 8934951. DOI: 10.1002/ehf2.13775.